Connect & Inspire

Share Your Story

Explore & Discover

Treatment & Care

Press Room

Subscribe

OSI’s New Family Fund Advances Osteosarcoma Research

“I'd like to believe that whatever we choose, it's going to help some child in some way, whether it lessens a side effect or just makes life a little easier,” Jennifer Wampler In the three years since the death of their daughter Lizzy to osteosarcoma, Jennifer...

LATEST POSTS

Connect & Inspire

Stories of inspiration, community, and survival 

Facing a Life-Threatening Disease with Your Partner

Facing a Life-Threatening Disease with Your Partner

When Oliver was diagnosed with osteosarcoma at age 20, Carys applied her nursing training to care for him throughout his treatment.
An International Dog Day Tribute to a Man’s Best Friend Lost to Osteosarcoma

An International Dog Day Tribute to a Man’s Best Friend Lost to Osteosarcoma

“Chief Texan” and popular podcaster, Jay B Sauceda, recalls Carl, his beloved Corgi who suffered from osteosarcoma, the most common bone cancer in adolescents and canines.
Turning a Cancer Diagnosis Into an Opportunity to Raise Awareness

Turning a Cancer Diagnosis Into an Opportunity to Raise Awareness

After Oliver was diagnosed with osteosarcoma, he decided to celebrate his 21st birthday with a fund-raiser to help other young people suffering from the disease.

Share Your Story

Fill out the form below to tell us about yourself. Sharing stories of osteosarcoma families helps us raise awareness and funds for much-needed research.

Gavin, Osteosarcoma Patient 

Explore & Discover

Stories of research, progress and exploration

The Osteosarcoma Institute to Announce New Grant Recipients

The Osteosarcoma Institute to Announce New Grant Recipients

A record 26 submissions will result in grantees who are working to transform research and treatment for osteosarcoma, a rare form of bone cancer ...
A Brief History of Osteosarcoma Treatment

A Brief History of Osteosarcoma Treatment

By Lee Helman, MD There has been a lack of improvement in outcomes for osteosarcoma patients over the last 40 years. Osteosarcoma is a very ...

Treatment and Care

Coming Soon!

Press Room

OSI News & updates

A Phase II clinical trial funded by The Osteosarcoma Institute is now enrolling

This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment

Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

Novel approach paves the way for vast expansion in the number of drugs targeting osteosarcoma

The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma

The Osteosarcoma Institute (OSI) announced today that it has awarded a grant to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for a Phase II single arm study of olaparib (an FDA-approved PARP inhibitor) and ceralacertib/AZD6738 (an investigational ATR kinase inhibitor) in ...

Instagram

Before You Go

Sign-up for our newsletter and stay up-to-date about our fight against Osteosarcoma!

Translate »